ResearcherPage View Count

Geo Map
AS - Asia3574
NA - North America1633
EU - Europe1465
HKU - The University of Hong Kong543
AF - Africa274
OC - Oceania117
SA - South America2
UND - Undefined70
CN - China2137
US - United States1551
GB - United Kingdom545
HKU - The University of Hong Kong543
HK - Hong Kong513
KR - Republic of Korea424
SG - Singapore342
IE - Ireland323
FR - France269
ZA - South Africa193
OTH - Others838
The University of Hong Kong543
Central District230
PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma104
Functional investigation and identification of dephosphorylation targets of tumor-suppressive protein tyrosine phosphatase, PTPRG145
Using next-generation whole-exome sequencing approaches to elucidate the genetic basis for nasopharyngeal carcinoma102
Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma112
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles133
Protein tyrosine phosphatase, receptor type G regulates tumorigenicity and invasion via AKT signaling in NPC29
Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis267
EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells91
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir200
Physiological β-catenin signaling regulates pluripotency genes in cancer microcell hybrids134
EBV infection suppresses the DNA repair mechanisms in nasopharyngeal epithelial cells via reduction of the H3K4m33 mark96
Functional and molecular analysis of the loss-of-function somatic mutations in two NF-κB pathway inhibitors: NFKBIA and CYLD in nasopharyngeal carcinoma40
Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma120
NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells158
Functional Characterization of a candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma.43
Involvement of a tumor suppressor gene, ADAMTS9, in Nasopharyngeal Carcinoma152
The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma85
IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling85
Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma228
Genetic and epigenetic landscape of nasopharyngeal carcinoma91
Nasopharyngeal carcinoma candidate tumor-suppressive ECM protein, LTBP2, mediates its effects via the pleiotropic transcription factor NF-κB pathway49
Functional studies of a cell cycle and angiogenesis-related candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma144
Functional characterization of a candidate tumor suppressor gene, Mirror Image Polydactyly 1, in nasopharyngeal carcinoma15
Tumor suppressive and angiogenic role of THSD1 in esophageal squamous cell carcinoma and nasopharyngeal carcinoma150
EBV-associated Histone Modifications in the Regulation of DNA Damage Repair Members Resulting in Cisplatin Resistance in Nasopharyngeal Carcinoma.39
Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma161
THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma190
Protein tyrosine phosphatase, receptor type G regulates Akt signaling in nasopharyngeal carcinoma44
Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma214
Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma52
Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma82
EBV-associated Histone Modifications in the Regulation of DNA Damage Repair Members in Nasopharyngeal Carcinoma.41
The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma (NPC)139
Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma196
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma133
Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma284
Aberrant methylation at chromosome 6p as novel biomarkers for diagnosis and prognosis of nasopharyngeal carcinoma150
CRIP2 is a candidate tumor suppressor in nasopharyngeal carcinoma associated with in vivo tumor suppression and angiogenesis inhibition163
ADAMTS9 inhibits angiogenesis and induces apoptosis in nasopharyngeal carcinoma153
The tumor suppressive role of IKBβ, a NFKB inhibitor, in Nasopharyngeal Carcinoma66
EBV-associated histone modifications in the regulation of DNA damage repair members resulting in cisplatin resistance in nasopharyngeal carcinoma33
Unraveling the genetic basis of nasopharyngeal carcinoma using next-generation sequencing approaches116
Identification of tumor suppressor genes via cell fusion and chromosomal transfer153
Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma76
Functional investigation of tumor and angiogenesis suppressive candidate tumor suppressor, cysteine-rich intestinal protein 2 in nasopharyngeal carcinoma120
THSD1: a candidate tumor suppressor attenuates angiogenesis, migratory and invasive potential of endothelial cells137
Roles of Tumor Suppressor Signaling on Reprogramming and Stemness Transition in Somatic Cells85
Functional analysis of a basement membrane protein, Nidogen-2 (NID2) in NPC and ESCC61
TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma248
SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma126
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults47
Functional and molecular analysis of the somatic mutations in the NF-ĸB pathway inhibitor, CYLD, in nasopharyngeal carcinoma.23
Functional Analysis of a Basement Membrane Protein, Nidogen-2 (NID2), in Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma32
Protein tyrosine phosphatase receptor type G regulates Akt- and β-catenin-associated epithelial-mesenchymal transition in nasopharyngeal carcinoma31
Whole-exome sequencing identifies genetic susceptibility locus associated with familial nasopharyngeal carcinoma92
Whole-exome sequencing identifies NF-kappaB pathway regulators frequently mutated in nasopharyngeal carcinoma113
Functional and Molecular Analysis of the Loss-of-Function Somatic Mutations in Two NF-KB Pathway Inhibitors30
EBV-associated histone modifications regulate DNA damage repair pathway and associate with cisplatin resistance in nasopharyngeal epithelial malignancy29
Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-κB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis246
Functional studies of a cell cycle and angiogenesis-related candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma119
Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma283
Functional investigation of tumor suppressor MIPOL1 in suppression of NPC tumorigenesis38
Deciphering the molecular genetic basis of NPC through functional approaches174
Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma230
Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma156